SHRO Founder Leads Search for Fauci Fellows

The National Italian American Foundation (NIAF) is now accepting applications for the inaugural class of Fauci Fellowships, created in recognition of Dr. Anthony S. Fauci’s contributions to humanity and the medical and scientific community. Antonio Giordano, M.D., Ph.D., Director and Professor, Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, serves on the … Continue reading SHRO Founder Leads Search for Fauci Fellows

International Research Collaboration to Address Delayed Diagnosis of Rare Gynecological Cancers

Sbarro Health Research Organization (SHRO) Founder and Director, Antonio Giordano, M.D., Ph.D., has recently published a landmark paper in collaboration with another 28 co-authors hailing from 14 different countries, as part of the GYNOCARE COST Action (CA18117). GYNOCARE is a European Network for Gynaecological Rare Cancer research: From Concept to Cure, which is chaired by … Continue reading International Research Collaboration to Address Delayed Diagnosis of Rare Gynecological Cancers

SHRO Professor to Discuss Russia’s COVID-19 Vaccine in Virtual Event with Columbia University Harriman Institute

Enrico Bucci, Ph.D., Adjunct Professor and long-time international collaborator with the Sbarro Health Research Organization (SHRO) at Temple University, will participate in a panel hosted by Columbia University's Harriman Institute on Monday, March 8, 2021, to discuss Russia's "Sputnik V" COVID-19 vaccine. The panel of experts will discuss recent trials that have demonstrated efficacy for … Continue reading SHRO Professor to Discuss Russia’s COVID-19 Vaccine in Virtual Event with Columbia University Harriman Institute

Getting Basic Research from the Lab to Independent Clinical Trials, Especially in Rare Cancers Like Mesothelioma

On the 18th and 19th of February, Sbarro Health Research Organization (SHRO) Founder and Director, Antonio Giordano, M.D., Ph.D., will host an online medical conference titled, “Why do we need independent research in oncology?” The topic of discussion will explore how to develop and foster independent research for tumors like Mesothelioma, for which insufficient funding … Continue reading Getting Basic Research from the Lab to Independent Clinical Trials, Especially in Rare Cancers Like Mesothelioma

Olive Leaf Extract Inhibits Breast and Ovarian Cancer Cell Growth and Cell Cycle Progression, Increasing Apoptosis of Tumor Cells

Breast and ovarian cancer are two of the deadliest malignancies among women worldwide. Furthermore, ovarian tumors are generally diagnosed at an already advanced stage and any specific treatment approach has still been individuated to effectively eradicate the disease with a good prognosis. Therefore, new strategies that could help to improve the progression-free survival (PFS) and … Continue reading Olive Leaf Extract Inhibits Breast and Ovarian Cancer Cell Growth and Cell Cycle Progression, Increasing Apoptosis of Tumor Cells

No Evidence Pets Play a Role in Spread of COVID to Humans

The emergence of Severe Acute Respiratory Syndrome (SARS) in 2003 and Middle East Respiratory Syndrome (MERS) in 2012, caused by SARS-CoVand MERS-CoV, respectively, demonstrated the zoonotic potential of coronaviruses. The new human coronavirus, Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2), responsible for the Coronavirus Disease 2019 (COVID-19), left its probable wild animal reservoir, has … Continue reading No Evidence Pets Play a Role in Spread of COVID to Humans

Cancer Survivor Dedicates Short Film to SHRO Founder

Researchers collaborating with the Sbarro Health Research Organization (SHRO) have frequently focused their precision medicine studies on improving outcomes and personalized therapies for breast cancer. Earlier this year, they examined the link between high BMI and low survival rates in HER2+ metastatic breast cancer, and they have pioneered the use of virtual reality in providing supportive care … Continue reading Cancer Survivor Dedicates Short Film to SHRO Founder

“We’ve got to get our act together” on public health measures to combat COVID, says Fauci

Anthony S. Fauci, M.D., NIAID Director In his remarks upon accepting the Leonardo da Vinci Award for Leadership in Health and Science, presented by the National Italian American Foundation (NIAF), Dr. Fauci signals optimism that one of the vaccines currently being tested will be shown to be effective, adding a very important tool in the … Continue reading “We’ve got to get our act together” on public health measures to combat COVID, says Fauci

National Italian American Foundation Honors Dr. Anthony Fauci with Leonardo da Vinci Award for Leadership in Health and Science, SHRO Founder Dr. Antonio Giordano Comments

https://vimeo.com/475909839 Dr. Fauci Interview National Italian American Foundation (NIAF) board member and Sbarro Health Research Organization (SHRO) founder and president Dr. Antonio Giordano congratulates Dr. Anthony Fauci on his awarding of the Leonardo da Vinci Award for Leadership in Health and Science at this year’s NIAF Anniversary Gala, held virtually on October 31st, 2020.  Antonio … Continue reading National Italian American Foundation Honors Dr. Anthony Fauci with Leonardo da Vinci Award for Leadership in Health and Science, SHRO Founder Dr. Antonio Giordano Comments

Hijacking cancer cells with a virus while blocking cells’ antiviral defenses could knock out mesothelioma

Malignant pleural mesothelioma (MPM) is a very aggressive cancer mainly caused by exposure to asbestos, against which no curative modalities exist, although many different strategies have been attempted so far. Research Alert A study exploring a new combination of therapeutic agents, dl922-947, an oncolytic adenovirus, and  AZD1775, an inhibitor of the DNA damage checkpoint kinase WEE1, … Continue reading Hijacking cancer cells with a virus while blocking cells’ antiviral defenses could knock out mesothelioma